Holen Sie sich die Stockscreener-App
178.70
1.62%
-2.94
Vorhandelsmarkt:
179.47
0.77
+0.43%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$181.64
Offen:
$180.9
24-Stunden-Volumen:
1.11M
Relative Volume:
1.13
Marktkapitalisierung:
$19.98B
Einnahmen:
$9.54B
Nettoeinkommen (Verlust:
$841.00M
KGV:
24.02
EPS:
7.44
Netto-Cashflow:
$1.02B
1W Leistung:
-0.92%
1M Leistung:
+4.59%
6M Leistung:
+3.35%
1J Leistung:
+13.84%
1-Tages-Spanne:
$178.31
$182.01
1-Wochen-Bereich:
$178.13
$182.35
52-Wochen-Spanne:
$146.17
$185.62
Quest Diagnostics Inc Stock (DGX) Company Profile
Firmenname
Quest Diagnostics Inc
Sektor
Branche
Telefon
(973) 520-2700
Adresse
500 PLAZA DRIVE, SECAUCUS
Vergleichen Sie DGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
178.70 | 20.31B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-01-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Fortgesetzt | Evercore ISI | In-line |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-29 | Eingeleitet | Piper Sandler | Neutral |
| 2023-05-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-01-23 | Eingeleitet | Evercore ISI | In-line |
| 2022-11-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-23 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-02 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Hochstufung | Argus | Hold → Buy |
| 2020-07-29 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-09 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Herabstufung | Goldman | Neutral → Sell |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-03-18 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-01-31 | Herabstufung | Argus | Buy → Hold |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Pattern recognition hints at Quest Diagnostics Incorporated upsideJuly 2025 Selloffs & Technical Confirmation Trade Alerts - Newser
How to interpret RSI for Quest Diagnostics Incorporated stockJuly 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
Should you wait for a breakout in Quest Diagnostics IncorporatedPortfolio Return Report & Fast Gain Stock Trading Tips - Newser
Statistical indicators supporting Quest Diagnostics Incorporated’s strengthDividend Hike & Accurate Entry/Exit Alerts - Newser
Can Quest Diagnostics Incorporated sustain its profitabilityJuly 2025 News Drivers & Weekly High Conviction Ideas - خودرو بانک
Published on: 2025-09-03 03:12:35 - خودرو بانک
Custom strategy builders for tracking Quest Diagnostics IncorporatedGold Moves & Capital Efficient Trading Techniques - Newser
Can Quest Diagnostics Incorporated expand into new marketsQuarterly Profit Report & Risk Managed Investment Signals - خودرو بانک
What are Quest Diagnostics Incorporated’s earnings expectations2025 Top Gainers & Precise Entry and Exit Recommendations - خودرو بانک
Is Quest Diagnostics Incorporated part of any major indexJuly 2025 Final Week & Consistent Growth Equity Picks - خودرو بانک
Quest Diagnostics Incorporated’s volatility index tracking explainedWeekly Trade Recap & Community Verified Trade Signals - Newser
Quest Diagnostics Incorporated stock momentum explainedMarket Activity Report & Fast Moving Stock Watchlists - Newser
707% Higher Fentanyl Rates: Quest Diagnostics Reveals Alarming Shift in Workplace Drug Testing Patterns - Stock Titan
How Investors May Respond To Quest Diagnostics (DGX) Expanding Michigan Lab Services Through Corewell Joint Venture - Yahoo Finance
Automated trading signals detected on Quest Diagnostics IncorporatedTrade Exit Report & Fast Exit Strategy with Risk Control - Newser
Developing predictive dashboards with Quest Diagnostics Incorporated data2025 Risk Factors & Fast Gain Stock Tips - Newser
Quest Diagnostics: Strategic Expansion and Market Dominance in the Evolving Lab Testing Industry - AInvest
Multi asset correlation models including Quest Diagnostics IncorporatedQuarterly Market Review & Community Supported Trade Ideas - Newser
What to do if you’re stuck in Quest Diagnostics IncorporatedWeekly Trade Summary & AI Optimized Trading Strategy Guides - Newser
Is Quest Diagnostics Incorporated a strong candidate for buy and hold2025 Year in Review & Smart Money Movement Alerts - خودرو بانک
What’s the recovery path for long term holders of Quest Diagnostics IncorporatedGold Moves & High Yield Equity Trading Tips - Newser
Quant Strategy Flags Quest Diagnostics Incorporated for EntryMarket Growth Review & Free Real-Time Market Sentiment Alerts - beatles.ru
Using AI based signals to follow Quest Diagnostics IncorporatedWeekly Trade Report & Community Verified Trade Alerts - Newser
What MACD and RSI say about Quest Diagnostics IncorporatedShare Buyback & Growth Focused Stock Pick Reports - Newser
Is Quest Diagnostics Incorporated stock reversal real or fakeForecast Cut & Growth-Oriented Investment Plans - Newser
Applying big data sentiment scoring on Quest Diagnostics Incorporated - Newser
Can you recover from losses in Quest Diagnostics IncorporatedPortfolio Growth Summary & Accurate Buy Signal Notifications - Newser
Multi factor analysis applied to Quest Diagnostics IncorporatedJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
How to use a screener to detect Quest Diagnostics Incorporated breakoutsEarnings Recap Report & Verified Chart Pattern Trade Signals - Newser
Measuring Quest Diagnostics Incorporated’s beta against major indices2025 Market Sentiment & Fast Moving Market Watchlists - Newser
Is Quest Diagnostics Incorporated stock bottoming outPortfolio Update Summary & Community Consensus Trade Alerts - Newser
Earnings visualization tools for Quest Diagnostics IncorporatedMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Quest Diagnostics Incorporated Forms Bullish Flag — Upside Ahead getLinesFromResByArray error: size == 0 - thegnnews.com
Identifying reversal signals in Quest Diagnostics IncorporatedJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - Newser
Published on: 2025-08-31 05:01:28 - Newser
Can Quest Diagnostics Incorporated recover in the next quarterJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - Newser
Short interest data insights for Quest Diagnostics IncorporatedPortfolio Value Report & Safe Entry Trade Signal Reports - Newser
Published on: 2025-08-30 21:13:45 - Newser
Finanzdaten der Quest Diagnostics Inc-Aktie (DGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):